"Occult Blood" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chemical, spectroscopic, or microscopic detection of extremely small amounts of blood.
| Descriptor ID |
D009780
|
| MeSH Number(s) |
E01.370.225.925 E05.200.925
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Occult Blood".
Below are MeSH descriptors whose meaning is more specific than "Occult Blood".
This graph shows the total number of publications written about "Occult Blood" by people in this website by year, and whether "Occult Blood" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 1 | 2 |
| 2017 | 2 | 0 | 2 |
| 2018 | 2 | 1 | 3 |
| 2019 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 4 | 4 |
| 2022 | 0 | 3 | 3 |
| 2024 | 1 | 2 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Occult Blood" by people in Profiles.
-
Optimal Stopping Ages for Colorectal Cancer Screening. JAMA Netw Open. 2024 Dec 02; 7(12):e2451715.
-
Characteristics of a cost-effective blood test for colorectal cancer screening. J Natl Cancer Inst. 2024 Oct 01; 116(10):1612-1620.
-
Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing. Cancer Epidemiol Biomarkers Prev. 2024 02 06; 33(2):215-223.
-
Stool-Based Tests Mitigate Impacts of COVID-19 on Colorectal Cancer Screening. Clin Gastroenterol Hepatol. 2023 06; 21(6):1667-1669.e2.
-
Persistent Disparities in Colorectal Cancer Screening: A Tell-Tale Sign for Implementing New Guidelines in Younger Adults. Cancer Epidemiol Biomarkers Prev. 2022 09 02; 31(9):1701-1709.
-
Assessing the impact of multicomponent interventions on colorectal cancer screening through simulation: What would it take to reach national screening targets in North Carolina? Prev Med. 2022 09; 162:107126.
-
Cost Effectiveness of Mailed Outreach Programs for Colorectal Cancer Screening: Analysis of a Pragmatic, Randomized Trial. Clin Gastroenterol Hepatol. 2022 10; 20(10):2383-2392.e4.
-
Colorectal Cancer Screening and Yield in a Mailed Outreach Program in a Safety-Net Healthcare System. Dig Dis Sci. 2022 09; 67(9):4403-4409.
-
Detection of High-Risk Sessile Serrated Lesions: Multitarget Stool DNA Versus CT Colonography. AJR Am J Roentgenol. 2022 04; 218(4):670-676.
-
Race and Gender Differences in Awareness of Colorectal Cancer Screening Tests and Guidelines Among Recently Diagnosed Colon Cancer Patients in an Urban Setting. J Cancer Educ. 2021 06; 36(3):567-575.